Read ASGCT's Third Quarter Landscape Analysis Field Report

ASGCT Staff - October 22, 2021

The third quarterly publication from ASGCT and Informa Pharma Intelligence, the Gene, Cell, & RNA Therapy Landscape report, is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

Highlights from the third issue in our partnership with Informa Pharma Intelligence include:

  • Approvals of two new gene therapies in the European Union (EU) and China
  • Expansion of two gene therapy approvals to new regions (South Korea and the EU)
  • Growth in the RNA therapeutic space of studies of anti-infective prophylactic vaccines
  • New this quarter: Spotlight on non-oncology indications

Read the Full Report

 

Click any of the samples below to view the full report:

 

Share This Page